Nyheter

Negotiations for 2025 have ended. FinELib consortium will not sign an agreement with American Chemical Society.

There will be no consortium agreement for 2024, but negotiations will continue for the year 2025.

New agreements will ensure continuation of open access publishing, guarantee access to journals, and keep the expenses of scientific publishing moderate.

Access to new, 2024 published ACS articles has been cut, and open access publishing under FinELib agreements has ended.

FinELib has made progress in negotiating with scholarly publishers, and negotiations continue in the new year.

Are you planning on publishing your article open access under a FinELib agreement? Check what you need to know.

Looking for better value 14.11.2023 Which scholarly journal agreements offer good value for money for higher education and research? Which agreements make a difference for open publishing, and which agreements give access to the most important journals? And above all, what is a fair and sustainable price for this? FinELib consortium is seeking answers to … Jatka artikkeliin Looking for better value

It’s no longer possible to publish open access at Nature journals with FinELib’s agreement.